Wim Wuyts

Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu, Martine Rémy‐Jardin, Christopher J. Ryerson et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 935 citations · Full text

ERS clinical practice guidelines on treatment of sarcoidosis

Robert P. Baughman, Dominique Valeyre, Peter Korsten et al. · European Respiratory Journal · 2021 · 541 citations · Full text

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial

Carlo Vancheri, Michael Kreuter, Luca Richeldi et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 286 citations

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial

Ganesh Raghu, Kevin M. Brown, Harold R. Collard et al. · The Lancet Respiratory Medicine · 2016 · 271 citations

Simtuzumab Versus Placebo, Idiopathic Pulmonary Fibrosis, Pulmonary Pharmacology +5